Natesto Testosterone Nasal Gel for Hypogonadal Men
Status:
Recruiting
Trial end date:
2026-06-01
Target enrollment:
Participant gender:
Summary
To determine if testosterone deficient men who are using daily Tadalafil (a
phosphodiesterase-5 Inhibitor), will have a significant improvement in erectile function and
satisfaction with erectile dysfunction treatment when using on-demand Testosterone Nasal Gel
(TNG) prior to sexual activity compared to placebo.